文献速递冠心病心律失常心力衰竭与心肌病

慢性冠脉综合征患者新发心房颤动的发生率、预测因素及心血管结局:CLARIFY注册研究

New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry.
PubMed 文献 · Eur Heart J · 2024-01-01

基于国际CLARIFY注册研究29 001例基线无房颤的慢性冠脉综合征门诊患者,5年随访中新发房颤/房扑发生率为每100患者年1.12(95%CI 1.06-1.18),5年累积发生率5.0%。新发房颤与心血管死亡、非致死性心肌梗死或非致死性卒中复合终点(aHR 2.01,95%CI 1.61-2.52)、心血管死亡(aHR 2.61)、全因死亡(aHR 2.27)、心衰住院(aHR 8.44)及大出血(aHR 4.46)风险显著增加相关。

要点

  • CCS患者5年新发房颤累积发生率为5.0%,发生率为每100患者年1.12。
  • 新发房颤使心衰住院风险增加8.44倍,心血管死亡风险增加2.61倍。
  • 年龄、BMI、低eGFR、白种人、饮酒及低LVEF为独立预测因素。

核心结论

  • 在慢性冠脉综合征患者中新发房颤常见,且与包括死亡、心衰住院及大出血在内的不良结局强烈相关。

研究设计与样本

  • 国际多中心(45个国家)前瞻性观察性CLARIFY注册研究,纳入29 001例基线无房颤的慢性冠脉综合征门诊患者,随访5年。

主要发现

  • 新发房颤发生率为每100患者年1.12(95%CI 1.06-1.18),5年累积发生率为5.0%。
  • 独立预测因素包括年龄增加、体重指数增加、估算肾小球滤过率低、白种人、饮酒及左心室射血分数低,而高甘油三酯与较低发生率相关。
  • 新发房颤与心血管死亡、非致死性心肌梗死或非致死性卒中复合终点调整风险比2.01(95%CI 1.61-2.52)相关。
  • 新发房颤与心血管死亡(aHR 2.61,95%CI 2.04-3.34)、非致死性心肌梗死(aHR 1.64,95%CI 1.07-2.50)、全因死亡(aHR 2.27,95%CI 1.85-2.78)相关。
  • 新发房颤与心衰住院(aHR 8.44,95%CI 7.05-10.10)及大出血(aHR 4.46,95%CI 2.85-6.99)相关。

临床怎么用

  • 对CCS患者应关注新发房颤的筛查,尤其合并高龄、肥胖、肾功能不全、饮酒或低LVEF者。
  • 新发房颤的CCS患者需加强心血管风险管控,警惕心衰住院及出血风险。

局限性

  • 观察性注册研究,新发房颤与不良结局的关联可能受残余混杂影响,无法确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Data on new-onset atrial fibrillation (NOAF) in patients with chronic coronary syndromes (CCS) are scarce. This study aims to describe the incidence, predictors, and impact on cardiovascular (CV) outcomes of NOAF in CCS patients. METHODS: Data from the international (45 countries) CLARIFY registry (prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease) were used. Among 29 001 CCS outpatients without previously reported AF at baseline, patients with at least one episode of AF/flutter diagnosed during 5-year follow-up were compared with patients in sinus rhythm throughout the study. RESULTS: The incidence rate of NOAF was 1.12 [95% confidence interval (CI) 1.06-1.18] per 100 patient-years (cumulative incidence at 5 years: 5.0%). Independent predictors of NOAF were increasing age, increasing body mass index, low estimated glomerular filtration rate, Caucasian ethnicity, alcohol intake, and low left ventricular ejection fraction, while high triglycerides were associated with lower incidence. New-onset atrial fibrillation was associated with a substantial increase in the risk of adverse outcomes, with adjusted hazard ratios of 2.01 (95% CI 1.61-2.52) for the composite of CV death, non-fatal myocardial infarction, or non-fatal stroke, 2.61 (95% CI 2.04-3.34) for CV death, 1.64 (95% CI 1.07-2.50) for non-fatal myocardial infarction, 2.27 (95% CI 1.85-2.78) for all-cause death, 8.44 (95% CI 7.05-10.10) for hospitalization for heart failure, and 4.46 (95% CI 2.85-6.99) for major bleeding. CONCLUSIONS: Among CCS patients, NOAF is common and is strongly associated with worse outcomes. Whether more intensive preventive measures and more systematic screening for AF would improve prognosis in this population deserves further investigation.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Gautier A, Picard F, Ducrocq G, et al. New-onset atrial fibrillation and chronic coronary syndrome in the CLARIFY registry. Eur Heart J. 2024. PMID: 37634147. doi:10.1093/eurheartj/ehad556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。